Outer Membrane Protein A from Escherichia coli Nissle 1917 Vesicles Alleviates Colon Inflammation by Modulating Specific Inflammatory Signaling Pathway
- 21 August 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
Abstract
Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal condition. Probiotic-derived outer membrane vesicles (OMVs) have emerged as a promising postbiotic strategy for IBD. Here, we evaluated the protective effects of Escherichia coli Nissle 1917 (EcN)-derived OMVs in a DSS-induced colitis mouse model using a pretreatment regimen. EcN OMVs attenuated colitis by improving the intestinal barrier and suppressing inflammatory responses, and this anti-inflammatory effect is largely attributed to outer membrane protein A (OmpA). OmpA-carrying EcN OMVs were associated with inhibition of excessive inflammation through a mechanism associated with suppression of TLR4/NF-κB signaling activation. Our work identifies potential mechanisms and key active components by which EcN OMVs may prevent intestinal inflammation. These results underscore the promise of EcN OMVs as functional food ingredients or dietary supplements for gut health maintenance.Keywords
Funding Information
- Key Programme (32330082)
- Natural Science Foundation of Jiangxi Province (20252BAC240711)
- Technological Project of Jiangxi Province (20232BCD44003)
- State Key Laboratory of Food Science and Resources (SKLF-ZZB-202543)
This publication has 50 references indexed in Scilit:
- Bacterial Extracellular Vesicles: Bridging Pathogen Biology and Therapeutic InnovationActa Biomaterialia, 2025
- Dietary probiotic-derived extracellular vesicles as delivery systems of bioactive compounds to maintain intestinal homeostasisChemical Engineering Journal, 2025
- The Effect of Clostridium butyricum‐Derived Lipoteichoic Acid on Lipopolysaccharide‐Stimulated Porcine Intestinal Epithelial CellsVeterinary Medicine and Science, 2025
- Roseburia intestinalis‐derived extracellular vesicles ameliorate colitis by modulating intestinal barrier, microbiome, and inflammatory responsesJournal of Extracellular Vesicles, 2024
- Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathwayAdvanced Drug Delivery Reviews, 2023
- Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applicationsBiotechnology Advances, 2023
- Anti‐Inflammatory Effect of Clostridium butyricum‐Derived Extracellular Vesicles in Ulcerative Colitis: Impact on Host microRNAs Expressions and Gut Microbiome ProfilesMolecular Nutrition & Food Research, 2023
- Fusobacterium nucleatum aggravates rheumatoid arthritis through FadA-containing outer membrane vesiclesCell Host & Microbe, 2023
- Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane VesiclesImmunity, 2019
- Correlation of Intestinal Mucosal Healing and Tight Junction Protein Expression in Ulcerative Colitis PatientsThe American Journal of the Medical Sciences, 2019